Celleo originated at the intersection of great biology and great engineering. Sparks fly at the intersection.
Our mission is to enable Cell & Gene Therapies to deliver population-level health outcomes, realizing the extraordinary potential of humanity’s most powerful therapeutic modality – our cells, augmented.
We contribute intelligent production systems for the manufacture of Cell & Gene Therapies.
Our 3 co-founders each bring nearly 20 years of deep industry experience in the development and production of Cell & Gene Therapies. Celleo develops GMP production systems in collaboration with leading commercial biotherapeutics players, developers of novel therapeutics at pre-clinical to clinical stage, CDMOs, and major university medical centers.